In a hospitalized patient who refuses basal insulin (Lantus insulin glargine) and metformin, preferring rapid‑acting insulin (Humalog insulin lispro) with an 8‑unit pre‑meal dose and a medium‑dose correction scale, should we continue this regimen with close blood‑glucose monitoring or switch to an alternative regimen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommendation: Do Not Continue Prandial-Only Insulin Without Basal Coverage

I strongly recommend adding basal insulin (Lantus) to the current regimen rather than continuing prandial Humalog alone, despite the patient's preference. Using only scheduled prandial insulin with correction doses (without basal insulin) is suboptimal and increases the risk of both hyperglycemia and hypoglycemia compared to a proper basal-bolus regimen.

Why Basal Insulin is Essential

The Endocrine Society guidelines explicitly state that prolonged use of sliding scale insulin (SSI) therapy alone should be avoided as the sole method for glycemic control in hyperglycemic patients with a history of diabetes during hospitalization 1. While your patient is receiving scheduled prandial doses (8 units with meals) rather than pure SSI, the absence of basal insulin creates a similar problem—reactive rather than proactive glucose management.

The evidence is clear: A basal-bolus regimen (basal insulin once or twice daily plus rapid-acting insulin before meals with correction doses) is the preferred treatment for hospitalized patients with adequate nutritional intake 1, 2, 3. This approach:

  • Reduces hospital complications (wound infections, pneumonia, bacteremia, renal/respiratory failure) 2
  • Provides better glycemic control than correction insulin alone 2
  • More closely mimics physiologic insulin secretion 1

The Problem with Prandial-Only Regimens

Without basal insulin, your patient lacks coverage for basal metabolic needs between meals and overnight. The 2012 Endocrine Society guidelines demonstrate that discontinuing diabetes medications and relying solely on reactive insulin approaches results in undesirable levels of both hypoglycemia and hyperglycemia, with one study showing a 3-fold increase in hyperglycemia risk 1. The 2021 Lancet guidelines confirm that sliding scale insulin alone is "associated with clinically significant hyperglycemia in many patients" 2.

Recommended Regimen

Calculate total daily dose (TDD) based on the patient's characteristics 1:

  • 0.2-0.3 units/kg/day if age ≥70 years OR GFR <60 mL/min
  • 0.4 units/kg/day if blood glucose 140-200 mg/dL
  • 0.5 units/kg/day if blood glucose 201-400 mg/dL

Distribute as 50% basal insulin and 50% nutritional (prandial) insulin 1:

  • Give Lantus once daily at the same time each day 1, 4
  • Continue Humalog before each meal (divide the prandial portion into three equal doses)
  • Add correction insulin using the "usual" column from the supplemental scale before meals 1

For example, if the patient weighs 80 kg and has no high-risk features:

  • TDD = 80 kg × 0.4 = 32 units
  • Basal (Lantus): 16 units once daily
  • Prandial (Humalog): ~5 units before each meal
  • Plus correction doses as needed

Addressing the Patient's Refusal

This is a patient safety issue that requires education and shared decision-making. The 2024 ADA guidelines emphasize that all patients with diabetes treated with insulin at home should be treated with a scheduled subcutaneous insulin regimen in the hospital 3.

Key points to discuss with the patient:

  • Basal insulin is not optional—it replaces the background insulin her pancreas cannot produce
  • Prandial-only insulin leaves dangerous gaps in coverage, especially overnight and between meals
  • The hospital setting increases insulin resistance due to stress, illness, and medications
  • Better glucose control reduces complications and may shorten hospital stay 2

If the patient continues to refuse Lantus specifically, consider:

  • NPH insulin twice daily as an alternative basal option (though less ideal due to peak action and hypoglycemia risk) 2
  • Documenting the refusal and having the endocrinology team consult if available
  • Explaining that inadequate glucose control may delay procedures or discharge

Critical Pitfalls to Avoid

  1. Do not rely on correction insulin alone—this reactive approach is condemned in all major guidelines 1, 2, 1, 3

  2. Do not accept metformin refusal without exploring reasons—if the concern is GI side effects or contraindications, document this, but metformin is often safely continued in hospitalized patients with normal renal function 5

  3. Monitor closely for hypoglycemia when initiating basal insulin, especially if the patient has poor oral intake, is elderly, or has renal impairment 2, 6, 7

  4. Hold prandial insulin if the patient cannot eat, but continue basal insulin with correction doses every 4-6 hours 1

If Patient Absolutely Refuses Basal Insulin

As a last resort, if the patient maintains informed refusal of basal insulin:

  • Increase monitoring frequency to before each meal and bedtime minimum
  • Use a basal-plus approach: Give a small dose of basal insulin (0.1-0.25 units/kg/day) with correction doses 2
  • Document extensively the patient's refusal, education provided, and risks explained
  • Involve diabetes care team or endocrinology for additional counseling 3
  • Plan for very close glucose monitoring and be prepared to escalate if control deteriorates

The current regimen of prandial insulin plus correction scale without basal coverage is not evidence-based and should not be continued without modification.

Related Questions

In a patient with severe hyperglycemia (blood glucose ~600 mg/dL) who is taking metformin 1000 mg twice daily, insulin glargine (Lantus) 18 units at bedtime, and low‑dose correctional (sliding‑scale) insulin, should the correctional insulin be changed to a high‑dose scale or should another adjustment to the insulin regimen be made?
How should I adjust the insulin and oral medication regimen for a patient with hemoglobin A1c 10% who is currently taking insulin glargine (Lantus) 16 U daily, insulin lispro (Admelog) 8 U per meal, and metformin 1000 mg twice daily?
Can regular (short‑acting) insulin be used to lower a blood glucose of 450 mg/dL in an adult?
With a random blood glucose of 290 mg/dL in a patient on basal insulin (~10 units daily) and metformin, how should the glucose be managed?
In a 51-year-old woman with recent left superior cerebellar infarct, normal renal function, weight 49.3 kg, currently on metformin 500 mg daily and basal insulin glargine (Lantus) 25 U with an insulin‑to‑carbohydrate ratio of 1 U per 12 g carbohydrate and an insulin sensitivity factor of 35 mg/dL per unit, and post‑prandial glucose values >200 mg/dL, what should the basal insulin dose, insulin‑to‑carbohydrate ratio, and insulin sensitivity factor be, and are any additional oral diabetes medications recommended?
What alternative medication can be used instead of brensocatib (Brinsupri) for non‑cystic fibrosis bronchiectasis?
In a patient requiring a second-line Helicobacter pylori eradication regimen where rifabutin is unavailable, can the therapy be switched to an alternative regimen based on local antibiotic resistance patterns?
Can trauma be stored in muscle tissue?
What are the stages of alcohol withdrawal and the recommended management for each stage?
What does the FROM JANE mnemonic stand for in infective endocarditis?
What baseline laboratory panel should be ordered for a 65-year-old female with type 2 diabetes mellitus as a new patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.